Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 30/03/2012
PIL Gadovist 1.0mmol/ml (Vials)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 30/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
Updated on 06/02/2012 and displayed until 30/03/2012
Reasons for adding or updating:
  • Change to date of revision
Updated on 01/08/2011 and displayed until 06/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 26/10/2010 and displayed until 01/08/2011
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 18/12/2009 and displayed until 26/10/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 23/09/2009 and displayed until 18/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Extra statutory information
Updated on 23/02/2009 and displayed until 23/09/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 20/05/2008 and displayed until 23/02/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Change to MA holder contact details
Updated on 14/08/2007 and displayed until 20/05/2008
Reasons for adding or updating:
  • Addition of separate PILs covering individual presentations

Active Ingredients/Generics

 
  gadobutrol